Centrum Medyczne Mrukmed

Rzeszów 35-922

1 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer, Non-Small Cell Lung Cancer, Pancreas Adenocarcinoma, Pancreatic Cancer

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• THIO Sequenced With Cemiplimab in Advanced NSCLC — Running, not enrolling
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) — Completed
• Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer — Completed
• Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine — Stopped early